Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong · Delayed Price · Currency is HKD
15.89
-0.11 (-0.69%)
Apr 21, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Consun Pharmaceutical Segment | 2.97B | 2.53B | 2.20B | 1.98B | 1.73B | | | | | |
Consun Pharmaceutical Segment Growth | 17.18% | 15.33% | 10.80% | 14.31% | 15.60% | | | | | |
Yulin Pharmaceutical Segment | 473.11M | 442.84M | 395.06M | 358.60M | 311.68M | | | | | |
Yulin Pharmaceutical Segment Growth | 6.84% | 12.09% | 10.17% | 15.05% | 22.85% | | | | | |
Elimination of Inter-segment Revenue | -22.25M | -7.12M | - | - | - | | | | | |
| 3.42B | 2.97B | 2.59B | 2.34B | 2.04B | | | | | |
| 15.17% | 14.56% | 10.71% | 14.43% | 16.65% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
People's Republic of China (PRC) | 3.42B | 2.97B | 2.59B | 2.34B | 2.04B | | | | | |
People's Republic of China (PRC) Growth | 15.17% | 14.56% | 10.71% | 14.43% | 16.65% | | | | | |
| 3.42B | 2.97B | 2.59B | 2.34B | 2.04B | | | | | |
| 15.17% | 14.56% | 10.71% | 14.43% | 16.65% | | | | | |
Source: S&P Global Market Intelligence.
